Groove Botanicals, Inc.
GRVE · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.14 | 0.42 | -1.03 |
| FCF Yield | -11.35% | -6.63% | -5.12% | -2.66% |
| EV / EBITDA | 0.00 | -7.74 | 0.00 | 0.00 |
| Quality | ||||
| ROIC | 0.00% | 3.17% | -8.96% | 3.23% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.11 | 0.52 | 0.58 | 0.78 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -81.38% | -9.36% | 30.04% | 39.47% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.07 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |